{"@context":{"@vocab":"https://schema.org/","dcterms":"http://purl.org/dc/terms/","prov":"http://www.w3.org/ns/prov#"},"@type":"ItemList","@id":"https://api.morvs.ai/api/v1/entity/SLAB/timeline","_source":{"data_provider":"AI Analytics","brand_name":"MORVS","brand_url":"https://morvs.ai/","data_provider_url":"https://api.morvs.ai","license":"https://api.morvs.ai/license","usage_info":"https://api.morvs.ai/license","rights":"Source-specific terms apply; free or keyless access does not alter them.","generated_at":"2026-10-19T13:07:56.527Z","methodology_url":"https://api.morvs.ai/datasets/","primary_sources":{"sec.*":"https://www.sec.gov/edgar","fda.*":"https://api.fda.gov/","contracts":"https://api.usaspending.gov/","clinical.trials":"https://clinicaltrials.gov/","lobbying.filings":"https://lda.senate.gov/","epa.facilities":"https://echo.epa.gov/","court.dockets":"https://www.courtlistener.com/","cfpb.complaints":"https://www.consumerfinance.gov/data-research/consumer-complaints/","nih.grants":"https://api.reporter.nih.gov/","fed.enforcement":"https://www.federalreserve.gov/supervisionreg/enforcementactions.htm","nhtsa.recalls":"https://api.nhtsa.gov/recalls/"}},"entity":{"entity_id":9029,"canonical_name":"SILICON LABORATORIES INC.","cik":"0001038074","uei":null,"lei":null,"duns":null,"ticker":"SLAB"},"window_days":180,"min_importance":0,"sources_queried":["sec.filings","sec.insider","sec.form144","sec.13dg","fda.recalls","fda.labels","contracts","clinical.trials","lobbying.filings","epa.facilities","uspto.patents","court.dockets","cfpb.complaints","nih.grants","fed.enforcement","nhtsa.recalls","doj.press","dol.form5500"],"importance_reference":{"fda.recall Class I":100,"clinical trial terminated":80,"securities class action":80,"antitrust suit":75,"schedule 13D":75,"patent litigation":70,"form144 large ($50M+)":75,"10-K restatement":75,"phase3 trial completed":70,"EPA significant violator":70,"phase3 trial in progress":60,"insider purchase":50,"phase2 trial":45,"8-K":35,"lobbying filing":30,"fda.label":30,"phase1 trial":30,"fda.recall Class III":25},"vertical_counts":{"sec":18},"count":18,"timeline":[{"ts":"2026-08-17","kind":"sec.filing","form_type":"4","title":"4 — SILICON LABORATORIES INC. — 2026-08-17","url_slug":"/sec/cik-0001038074/4/0001628280-26-057312","accession_number":"0001628280-26-057312","importance":30},{"ts":"2026-08-14","kind":"sec.insider.s","reporter":"CONRAD ROBERT J","title":"Sr VP and General Manager","shares":6581,"price_per_share":218.21,"usd_value":1436040,"security_title":"Common Stock, $0.0001 par value","importance":36.43604001},{"ts":"2026-08-14","kind":"sec.filing","form_type":"144","title":"144 — SILICON LABORATORIES INC. — 2026-08-14","url_slug":"/sec/cik-0001038074/144/0001959173-26-006015","accession_number":"0001959173-26-006015","importance":30},{"ts":"2026-08-11","kind":"sec.filing","form_type":"10-Q","title":"10-Q — SILICON LABORATORIES INC. — 2026-08-11","url_slug":"/sec/cik-0001038074/10-q/0001038074-26-000029","accession_number":"0001038074-26-000029","importance":45},{"ts":"2026-08-11","kind":"sec.filing","form_type":"8-K","title":"8-K — SILICON LABORATORIES INC. — 2026-08-11","url_slug":"/sec/cik-0001038074/8-k/0001038074-26-000027","accession_number":"0001038074-26-000027","importance":35},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — SILICON LABORATORIES INC. — 2026-05-19","url_slug":"/sec/cik-0001038074/4/0001628280-26-036282","accession_number":"0001628280-26-036282","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — SILICON LABORATORIES INC. — 2026-05-19","url_slug":"/sec/cik-0001038074/4/0001628280-26-036285","accession_number":"0001628280-26-036285","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — SILICON LABORATORIES INC. — 2026-05-19","url_slug":"/sec/cik-0001038074/4/0001628280-26-036287","accession_number":"0001628280-26-036287","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — SILICON LABORATORIES INC. — 2026-05-19","url_slug":"/sec/cik-0001038074/4/0001628280-26-036289","accession_number":"0001628280-26-036289","importance":30},{"ts":"2026-05-19","kind":"sec.filing","form_type":"4","title":"4 — SILICON LABORATORIES INC. — 2026-05-19","url_slug":"/sec/cik-0001038074/4/0001628280-26-036292","accession_number":"0001628280-26-036292","importance":30},{"ts":"2026-05-18","kind":"sec.form144","reporter":"Johnson Robert Matthew","title":"Officer, Director","shares":8024,"usd_value":1739844,"security_title":"Common","approx_sale_date":"2026-05-18","accession_number":"0001959173-26-003676","importance":40.347968784},{"ts":"2026-05-18","kind":"sec.insider.s","reporter":"Johnson Robert Matthew","title":"President & CEO","shares":8024,"price_per_share":216.83,"usd_value":1739844,"security_title":"Common Stock, $0.0001 par value","importance":36.73984392},{"ts":"2026-05-18","kind":"sec.filing","form_type":"144","title":"144 — SILICON LABORATORIES INC. — 2026-05-18","url_slug":"/sec/cik-0001038074/144/0001959173-26-003676","accession_number":"0001959173-26-003676","importance":30},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Johnson Robert Matthew","title":"President & CEO","shares":10363,"price_per_share":216.59,"usd_value":2244522,"security_title":"Common Stock, $0.0001 par value","importance":17.24452217},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Butler Dean Warren","title":"Sr VP and CFO","shares":6291,"price_per_share":216.59,"usd_value":1362568,"security_title":"Common Stock, $0.0001 par value","importance":16.36256769},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"Tolany Brandon","title":"Sr VP WW Sales & Marketing","shares":4160,"price_per_share":216.59,"usd_value":901014,"security_title":"Common Stock, $0.0001 par value","importance":15.9010144},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"CONRAD ROBERT J","title":"Sr VP and General Manager","shares":3653,"price_per_share":216.59,"usd_value":791203,"security_title":"Common Stock, $0.0001 par value","importance":15.79120327},{"ts":"2026-05-15","kind":"sec.insider.f","reporter":"MAULDIN MARK D","title":"Chief Accounting Officer","shares":858,"price_per_share":216.59,"usd_value":185834,"security_title":"Common Stock, $0.0001 par value","importance":15.18583422}]}